NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration
Clinical trial NCT05984927 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05984927
- Sponsor
- Elisigen, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2026-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.